Search results
Results from the WOW.Com Content Network
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.
Causes and risk factors of VTS include age, a high degree of myopia or nearsightedness, macular degeneration, diabetic retinopathy, macular edema, and occlusion of the retinal vein. [3] Treatment for VTS depends on the severity and how much vision is affected. For some people, regular monitoring may be suggested ("wait and see approach").
Intraretinal microvascular abnormalities (IRMA) are abnormalities of the blood vessels that supply the retina of the eye, a sign of diabetic retinopathy. [1] IRMA can be difficult to distinguish from and is likely a precursor to retinal neovascularization. One way to distinguish IRMA from retinal neovascularization is to perform fluorescein ...
4. Diabetic Retinopathy Complications. Diabetic retinopathy is an eye condition that only affects people with diabetes. It results from damage to the blood vessels in the eyes and can lead to ...
In patients with diabetes mellitus, regular fundus screening examinations (once every six months to one year) are important to screen for diabetic retinopathy as visual loss due to diabetes can be prevented by retinal laser treatment if retinopathy is spotted early.
Treatment is based on the cause of the retinopathy and may include laser therapy to the retina. Laser photocoagulation therapy has been the standard treatment for many types of retinopathy. Evidence shows that laser therapy is generally safe and improves visual symptoms in sickle cell and diabetic retinopathy.
Diabetic retinopathy [3] [4] [5] Other ischemic retinopathies including central retinal vein occlusion (CRVO), [6] branch vein occlusion (BVO), and sickle cell retinopathy; Toxic retinopathies, including those caused by Plaquenil and Vigabatrin. The ERG is also used to monitor retinal toxicity in many drug trials.
With specific training, in some countries orthoptists may be involved in monitoring of some forms of eye disease, such as glaucoma, cataract screening and diabetic retinopathy. [ 3 ] Effectiveness